Hook & thesis
Core Scientific is no longer just a bitcoin miner. The combination of an announced strategic partnership with AMD, a rapid acceleration in colocation revenue, and a $500 million financing facility to fund expansion materially changes the company's trajectory. If execution on the AMD agreement and the colocation buildout proceeds as signaled, Core Scientific should re-rate from a distressed miner multiple toward peers in high-density AI hosting.
That makes Core Scientific (CORZ) a buy here with a disciplined plan: enter at $22.82, target $30.00 and stop at $18.00. The trade is explicitly directional and conviction-based — not a bet on a cyclical bitcoin rally but on durable, higher-margin revenue from hosting AI workloads and the monetization of leased capacity over the next 6 months.
Why the market should care - business overview and fundamental driver
Core Scientific operates two businesses: self-mining bitcoin and hosting third-party customers in purpose-built, high-density facilities. The core fundamental driver that matters now is the hosting business. High-density colocation commands much higher and more stable dollar-per-megawatt economics than opportunistic self-mining, because customers (AI companies, cloud providers, systems integrators) pay contracted fees for reliable power, cooling and real estate.
Recent operational signals show the pivot is real. Colocation revenue jumped to $65 million in 2025 from $24 million in 2024, a near tripling that demonstrates early commercial traction in leasing capacity for compute workloads. That shift reduces exposure to bitcoin price volatility and increases revenue visibility as long-term leases replace stochastic mining rewards.
Supporting data points
- Current share price: $22.82 and market cap roughly $7.33 billion.
- Enterprise value is approximately $9.86 billion and EV/sales sits at ~22.4x on the reported numbers.
- Colocation revenue: $65M in 2025 versus $24M in 2024, showing material y/y expansion.
- Q4 revenue weakness was reported (revenue down to $79.76M from $94.9M in a prior period), but underlying hosting growth presents a path to stabilization.
- Financing: a $500M 364-day loan facility arranged with Morgan Stanley (accordion to $1B) provides near-term capital to fund data-center buildouts.
- Balance-sheet and profitability caveats: trailing adjusted EPS is negative (-$4.29), free cash flow is negative (around -$957.7M), and adjusted EBITDA remains negative; the company is still burning cash while scaling.
- Market dynamics: short interest is elevated (~63M shares recently), representing meaningful crowd skepticism but also liquidity for momentum moves; days-to-cover ranges around 5-6 days.
Valuation framing
On surface multiples Core Scientific looks expensive: EV/sales near 22x and price-to-sales north of 16x. Those multiples are high because trailing revenue is still modest while the market prices in a substantial rerating toward future hosting scale and higher-margin AI workloads. At the same time, the company is loss-making with negative free cash flow, so the valuation is conditional on execution.
Practically, the upside implied by our target is modest: reaching $30.00 (roughly the prior 52-week high of $30.46) implies a re-rating to a valuation that reflects successful scale of the hosting business rather than a full disconnect from fundamentals. The market cap at $30 would be about $9.6B (holding shares outstanding constant), still below enterprise-value driven scenarios where Core Scientific demonstrates durable high-density utilization and long-term contracts with hyperscalers.
Catalysts
- AMD partnership - The announced agreement with AMD should accelerate deployments of optimized AI server blades inside Core Scientific facilities and improve go-to-market for enterprise customers. While exact commercial terms haven't been widely disclosed, the credibility of an AMD-backed hosting offering materially reduces customer friction and shortens sales cycles.
- Financing availability - The $500M Morgan Stanley 364-day facility (accordion to $1B) announced on 03/05/2026 funds the near-term buildout of leasable capacity and buys time to lease up equipment without immediate balance-sheet strain.
- Rapid colocation revenue growth - Colocation revenue rose to $65M in 2025 from $24M in 2024. Continued quarterly growth would validate revenue predictability and improve multiple expansion.
- Large customer wins / long-term leases - Public or verifiable multi-year leases with AI operators (even single-digit MW contracts) would provide headline-grabbing revenue visibility and help justify a higher multiple.
- Bitcoin cycle insulation - As the company continues to reduce self-mining and convert capacity to hosting, its earnings volatility should fall and investor risk appetite for the name should increase.
Trade plan (actionable)
Thesis: Long exposure to CORZ to capture re-rating as AMD-enabled AI hosting and colocation revenue scale begins to show consistent sequential growth and margin improvement.
| Entry | Target | Stop | Position Size Reminder |
|---|---|---|---|
| $22.82 | $30.00 | $18.00 | Size the position so the stop loss represents no more than 2-4% of total portfolio risk (position sizing discipline is critical given operating losses). |
Time horizon: long term (180 trading days). Why 180 days? The AMD partnership, leasing cycles and financing-driven capacity buildouts will take several quarters to translate into booked revenue and visible margin improvement. Give the company two to three quarters to demonstrate sequential colocation revenue growth, reduced cash burn and improved adjusted EBITDA before reassessing the thesis.
How to manage the trade
- Enter at or within a tight band of $22.82. If the name gaps significantly above $25 on day-one news, scale in rather than paying up full size.
- If price reaches $30.00, take profits on at least half the position and move the stop to breakeven on the remainder to capture further upside while protecting capital.
- If the stock breaches $18.00 on a weekly close accompanied by negative fundamental news (e.g., AMD deal falls through, materially worse cash burn, or lost financing), exit and reassess.
Risks and counterarguments
Core Scientific is a high-risk, high-reward situation. Below are the principal risks and a counterargument to the bull case:
- Execution risk on the AMD deal - The reported AMD partnership is material to the thesis. If integration stalls, commercial economics are unfavorable, or the agreement fails to bring customers to the facilities, the re-rating will not occur.
- Negative cash flow and leverage - Free cash flow is deeply negative (about -$957.7M) and the company remains loss-making (EPS -$4.29). Continued cash burn could require dilutive equity raises or more expensive financing, both of which would cap upside.
- Customer concentration and sales timing - Winning and ramping large AI customers takes time. If bookings are pushed out, revenue growth will lag capital deployment and financing costs will rise.
- Macro and capital markets - A risk-off environment would compress multiples for speculative infrastructure names and make refinancing or accordion draws less attractive.
- Regulatory and crypto volatility - Although the company is pivoting away from pure mining, residual exposure to cryptocurrency operations and regulatory shifts in energy policy could create headline risk and operational constraints.
- High short interest and volatility - Elevated short interest (~63M shares) implies volatile moves and the potential for sharp downside if negative catalysts hit; it also makes the stock prone to large intraday swings driven by flows rather than fundamentals.
Counterargument: Skeptics will point to the stretched headline multiples (EV/sales ~22x) and ongoing negative cash flow as proof the market is pricing hope, not reality. If colocation growth disappoints or the AMD arrangement is less commercial than advertised, the stock could retrace sharply. That’s why the stop at $18.00 is non-negotiable for this trade.
Conclusion - what would change my mind
Core Scientific merits a long here because the AMD partnership materially shortens sales cycles and adds product credibility, the company has access to near-term financing to build capacity, and colocation revenue has already shown a step-change increase. The trade pays to be patient: give the company 180 trading days to show sequential revenue growth, margin improvement, and evidence that AMD-enabled deployments convert to contracted revenue.
I would change my view if any of the following occur: (1) the AMD partnership is terminated or materially watered down, (2) colocation revenue does not show clear sequential growth over the next two quarters, (3) the company is forced to raise equity at a deep discount or violates loan covenants, or (4) adjusted EBITDA declines further without a credible path to stabilization.
For disciplined traders who can size risk and accept volatility, CORZ offers an asymmetric trade: substantial upside if the AMD partnership and colocation buildout execute, tempered by clear stop-loss discipline to limit downside in the event the thesis stalls.
Trade idea: Buy Core Scientific at $22.82, target $30.00, stop $18.00. Hold long term (180 trading days) and reassess on concrete top-line and margin evidence.